Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Catamaran’s BriovaRx Receives URAC Specialty Pharmacy Accreditation

April 4, 2013

LISLE, IL, April 4, 2013 /PRNewswire/ - Catamaran Corp. (NASDAQ: CTRX), (TSX: CCT), a leading provider of
pharmacy benefit management (PBM) services and technology today
announced that its specialty brand, BriovaRx(TM), has been awarded
Specialty Pharmacy Accreditation from URAC, a Washington, D.C.-based accrediting organization that
establishes quality standards for the healthcare industry.

“BriovaRx’s robust offerings focus on the patient, ensuring one-on-one
support and a personalized plan that addresses chronic conditions to
help them lead healthy, vibrant lives,” said Mark Thierer, Chairman and
CEO of Catamaran. “The URAC accreditation is a reflection of BriovaRx’s
patient-centric approach that coordinates the efforts of providers,
payers and manufacturers to keep treatments personalized and
successful.”

Designed as a better alternative to other specialty pharmacy offerings,
BriovaRx is a high-touch, comprehensive care system of pharmacological
care where patients with chronic illnesses and complex diseases receive
expert therapy management and support tailored to their individual
needs.

URAC made the decision to develop a Specialty Pharmacy accreditation
program because it is one of the key distribution channels for pharmacy
benefit management and extends URAC’s consumer protection and
empowerment efforts in managed care pharmacy. URAC offers the only
third-party, voluntary accreditation program of this scope for pharmacy
benefit management and prescription services industry.

“The URAC accreditation is a recognition of the quality and broad scope
of our specialty pharmacy offering,” said Albert Thigpen, Senior Vice
President, Pharmacy Operations of Catamaran. “As the fifth largest
specialty pharmacy in the nation, BriovaRx has the skill and scale to
effectively manage costs for health plans and other payers challenged
by escalating specialty drug prices and increased utilization. We look
forward to continuing to deliver personalized care and committed
support to our patients.”

“By applying for and receiving URAC accreditation, BriovaRx has
demonstrated a commitment to quality healthcare,” said Alan P.
Spielman, URAC president and CEO. “Quality healthcare is crucial to our
nation’s welfare and it is important to have organizations that are
willing to measure themselves against national standards and undergo
rigorous evaluation by an independent accrediting body.”

About Catamaran
Catamaran, the industry’s fastest-growing pharmacy benefit manager,
helps organizations and the communities they serve take control of
prescription drug costs. Managing more than 250 million prescriptions
each year on behalf of 25 million members, our flexible, holistic
solutions improve patient care and empower individuals to take charge
of their health. Processing one in every five prescription claims in
the U.S., Catamaran’s skill and scale deliver compelling financial
results and sustainable improvement in the overall health of members.
Catamaran is headquartered in Lisle, Ill. with multiple locations in
the U.S. and Canada. For more information, please visit www.catamaranRx.com. Follow us on Twitter @CatamaranCorp or www.twitter.com/catamarancorp.

About URAC
URAC, an independent, nonprofit organization, is a leader in promoting
health care quality through accreditation and certification programs.
URAC’s standards keep pace with the rapid changes in the health care
system, and provide a mark of distinction for health care organizations
to demonstrate their commitment to quality and accountability. Through
its broad-based governance structure and an inclusive standards
development process, URAC ensures that all stakeholders are represented
in setting meaningful standards for the health care industry. For more
information, visit www.urac.org.

SOURCE Catamaran


Source: PR Newswire